Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer

Author： Koliadi Anthoula   Nilsson Cecilia   Holmqvist Marit   Holmberg Lars   de La Torre Manuel   Wärnberg Fredrik   Fjällskog Marie-Louise  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.49, Iss.6, 2010-08, pp. : 816-820

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aberrant expression of cyclin E in low-risk node negative breast cancer

By Ahlin Cecilia   Gruhne Bettina   Holmqvist Marit   Zetterberg Anders   Fjallskog Marie-Louise  

Acta Oncologica, Vol. 47, Iss. 8, 2008-01 ,pp. : 1539-1545

Informa Healthcare

Access to resources Recommend Favorite

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

By Melisko Michelle  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 45-47

Informa Healthcare

Access to resources Recommend Favorite

Tools to Predict Breast Cancer Risk

By  

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 5-6

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Inflammatory cells in node-negative breast cancer

By Löfdahl Britta   Ahlin Cecilia   Holmqvist Marit   Holmberg Lars   Zhou Wenjing   Fjällskog Marie-Louise   Amini Rose-Marie  

Acta Oncologica, Vol. 51, Iss. 5, 2012-05 ,pp. : 680-686

Informa Healthcare

Access to resources Recommend Favorite

Prognostic variables in node-negative and node-positive breast cancer - Introduction

By Gasparini G.  

Breast Cancer Research and Treatment, Vol. 51, Iss. 3, 1998-10 ,pp. : 193-194

Springer Publishing Company

Access to resources Recommend Favorite